Breaking News on Pharmaceutical Technology

Product news > Drug delivery systems

Latest news headlines

Products

Suppliers

3M opens first Asia-Pacific R&D lab in Singapore

08-Oct-2009 - US firm 3M Drug Delivery Systems has set its sights on the Asia-Pacific region, with a new lab in Singapore which, it says, will help it better serve both local and international markets.

Genentech licenses SurModics tech for SR Lucentis

07-Oct-2009 - Its new microparticle technology licensing deal with Genentech could be worth as much as $200m (€136m) says US delivery specialist SurModics.

MannKind’s shares tumble; deal unlikely in 2009

07-Oct-2009 - MannKind’s share price tumbled by 31 per cent yesterday, just days after it published encouraging safety data for Afresa, because it revealed a partnership deal is unlikely to occur in 2009.

News in brief

India’s formulation market worth $14bn by 2013, says Angel Broking

05-Oct-2009 - India’s drug formulation market will grow 12 per cent a year and be worth $13.7bn (€9.3bn) by 2013, according to new research by market analysts Angel Broking.

OctoPlus reduces workforce by 25% to boost efficiency

29-Sep-2009 - Dutch contract delivery services firm OctoPlus says it will cut 35 jobs as part of ongoing efforts to boost efficiency, improve competitiveness and broaden its client base and revenue streams.

West opens its first manufacturing site in China

28-Sep-2009 - West has opened its first manufacturing facility in China to meet rising demand but the process has taken since 2006 and been “very tedious”, its president of West Asia Pacific told Outsourcing-Pharma.

News in brief

EC OKs Novartis’ move for Ebewe SP's injectables biz

24-Sep-2009 - The European Commission has approved Novartis’ €925m ($1.2bn) acquisition of Ebewe Spezial-Pharma’s generic injectables business.

News in brief

Octoplus lands CF drug deal with Axentis

14-Sep-2009 - Octoplus has signed a new contract with develop and manufacture Axentis Pharma’s lead product, a candidate cystic fibrosis treatment.

Biologics boost for $2.7bn needle-free delivery market

14-Sep-2009 - Demand for new delivery options for biologic drugs will drive an expansion of the $2.7bn needle-free technology market over the medium-term, according to a new report by industry analysts Kalorama Information.

Targeted Genetics out of crisis after selling AAV kit to Genzyme

10-Sep-2009 - Struggling biotech Targeted Genetics (TG) has sold certain patents and AAV manufacturing technology to fellow US group Genzyme in a $7m deal that “shifts the firm out of crisis mode,” according to CEO Susan Robinson.

Encap targets growth opportunities in colonic delivery

08-Sep-2009 - CMO Encap has expanded its colonic delivery offering and is combining the technology with liquid dosage forms to provide clients with a way to administer a wide range of therapeutics to the region.

Novavax’ VLP delivery tech could accelerate H1N1 vacc production

08-Sep-2009 - Novavax’ VLP delivery system has been the subject of industry excitement this week after the US firm released Ph II data showing that a combination seasonal influenza vaccine based on the technology is effective and well tolerated.

Controlled-release can deliver for generics firms, says Espicom

03-Sep-2009 - Wyeth’s battles to protect the controlled-release (CR) version of its anti-depressant Effexor are a sign of things to come according to a new Espicom report identifying 30 CR drugs likely to face competition.

News in brief

Novartis buys HySolv technology from BTG

02-Sep-2009 - Swiss drug major Novartis will UK specialty pharma firm BTG up to $10m (€7m) for its HySolv drug delivery technology.

Durect and King sign long-term Remoxy excipient supply deal

31-Aug-2009 - Chemicals firm Durect will supply drugmaker King Pharmaceuticals with two excipients used in the manufacture of the candidate anti-abuse painkiller Remoxy in an agreement signed last week.

Silence collaborating on AtuRNAi drug delivery tech

27-Aug-2009 - Dainippon Sumitomo Pharma has entered into a collaboration to develop Silence Therapeutics’ AtuRNAi delivery technology which improves stability, cut manufacturing costs and increase stability.

Microneedle patch could boost compliance

24-Aug-2009 - Researchers have presented new microneedle drug delivery patches, which, using technology developed in the electronics sector, could improve compliance and treat ocular diseases.

Dry powder vaccine nears Phase I

18-Aug-2009 - A dry powder measles vaccine formulation and inhalers that could be as affordable as needle treatments are due to enter Phase I in 2010, according to researchers at the ACS meeting.

LSO trials light activated cancer treatment

13-Aug-2009 - Light Sciences Oncology (LSO) has begun treating the first patient in a Phase I trial of Aptocine (alaporfin sodium), a drug activated by an LED device inserted into a tumour.

Aptamers used for targeted cancer treatment

11-Aug-2009 - Researchers have developed a drug delivery vehicle using liposomes and aptamers that targets specific cancer cells and can be switched off to stop adverse reactions.

Positive Phase II for intranasal antiemetic

04-Aug-2009 - Shin Nippon Biomedical Laboratories (SNBL) has posted a positive first report on the Phase II trial of its intranasal antiemetic, which it claims is a more convenient treatment for cancer patients.

Medingo’s insulin patch approved; shares rocket

30-Jul-2009 - Medingo’s insulin dispensing patch has been approved by the US Food and Drug Administration (FDA), sending shares in its parent company soaring to a 12 month high.

New liquid protein tech could improve drug delivery

28-Jul-2009 - Scientists at the University of Bristol in the UK and the Max Planck in Germany have developed the world’s first “liquid protein” that could have a big impact on the delivery of therapeutic proteins and high-potency pharmaceuticals.

West buys Plastef’s delivery business

09-Jul-2009 - US contract manufacturer West Pharmaceutical Services has purchased French device firm Plastef Investissements’ drug delivery business, adding the eris safety syringe system to its offering.

3M rolls out plasma coating and face seal tech for pMDIs

10-Jun-2009 - 3M’s drug delivery unit believes its new plasma coating and face seal valve pMDI technologies help protect APIs and will mean that more drugs can be delivered via inhalation.

Sign up for your free newsletter